Appalachian Mind Health Initiative (AMHI)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04120285 |
Recruitment Status :
Recruiting
First Posted : October 9, 2019
Last Update Posted : June 9, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Major Depressive Disorder | Behavioral: remote internet-based cognitive behavior therapy (eCBT) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 3360 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | There are three treatment arms: 1) treatment as usual 2) treatment as usual with unguided eCBT and 3) treatment as usual with guided eCBT |
Masking: | None (Open Label) |
Masking Description: | Participant recruiters will be blinded to the participant's intended treatment arm. Survey data collectors will be blinded to each participant's treatment arm. |
Primary Purpose: | Treatment |
Official Title: | Remote Cognitive Behavior Therapy for Major Depression (RTD) in Primary Care |
Actual Study Start Date : | January 9, 2021 |
Estimated Primary Completion Date : | February 1, 2025 |
Estimated Study Completion Date : | July 1, 2025 |
Arm | Intervention/treatment |
---|---|
No Intervention: Primary Care Treatment
The participant will receive treatment as usual as prescribed by the primary care physician for MDD.
|
|
Active Comparator: Primary care treatment with eCBT
The participant will receive treatment as usual as prescribed by the primary care physician with the addition of eCBT for MDD.
|
Behavioral: remote internet-based cognitive behavior therapy (eCBT)
Provide access to online psychotherapy program to participants in rural WV areas at no expense to them. |
Active Comparator: Primary care treatment with guided eCBT
The participant will receive treatment as usual as prescribed by the primary care physician with the addition of guided eCBT for MDD.
|
Behavioral: remote internet-based cognitive behavior therapy (eCBT)
Provide access to online psychotherapy program to participants in rural WV areas at no expense to them. |
- RDQ-7 [ Time Frame: 16-Week Follow-up ]Investigators will assess all study patients remission from depression with the Remission from Depression Questionnaire (RDQ-7) via self-report assessments at 16 week follow-up. Investigators will monitor patients at 26, 39, and 52 weeks to evaluate the long-term maintenance of remission (or recurrence). The RDQ-7 is a measure with 41 items. Items are reported on a 3-point rating scale (0=not at all or rarely true; 1 = sometimes; 2 = often or almost always true). The total scale score ranges from 0-82. Participants with a total score below or equal to 27 are considered in remission. Higher total scores reflect greater pathology.
- PROMIS Short Form v1.0 - Severity of Substance Use (past 30 days) [ Time Frame: 16 week Follow-up ]The investigators will assess all study participants severity of substance use using the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Severity of Substance Use (past 30 days) at 16 week follow-up. Investigators will monitor participants at 26, 39, and 52 weeks to evaluate the long-term durability of our intervention. The PROMIS) Short Form v1.0 - Severity of Substance Use (past 30 days) is a measure with 7 items. Items are reported with five response options ranging in value from one to five. To calculate the total scale score, items are summed resulting in a range from 1-35. Higher total scores reflect that a participant uses a substance with greater severity.
- Compliance with Antidepressant Medication Treatment [ Time Frame: 16 week Follow-up ]The investigators will assess all study participants adherence to antidepressant medication (if applicable) using electronic medical record data at 16 week follow-up. Investigators will monitor participants at 26, 39, and 52 weeks to evaluate the long-term durability of our intervention. Electronic medical record data will be examined for antidepressant medication prescriptions and prescription refills or changes.
- SDM-Q-9 [ Time Frame: 52 week Follow-up ]The investigators will assess all study participants involvement with shared decision-making regarding depression treatment provided by their primary care physician using the Shared Decision Making Questionnaire (SDM-Q-9) at 52 week follow-up. The SDM-Q-9 is a nine item measure. Items are reported with six response options ranging from 0, "completely disagree", to 5, "completely agree". To calculate the total scale score, items are summed resulting in a range from 0-45. Higher scores reflect a participant's participation in shared decision making regarding their treatment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
- seeking MDD treatment for the first time in the past 6 months (i.e., the beginning of a first or new course of treatment),
- appropriate for outpatient treatment,
- literate in English,
- has access to a smart phone, home computer or willing to travel to access a computer
- without hearing or vision or cognitive impairment that would interfere with research data collection
- without history of either bipolar disorder or non-affective psychosis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04120285
Contact: Robert Bossarte, PhD | 813-396-2739 | rbossarte@usf.edu | |
Contact: Maria Martik | 813-396-0303 | mariamartik@usf.edu |
United States, Kentucky | |
University of Lousiville Health | Recruiting |
Louisville, Kentucky, United States, 40202 | |
Contact: Becky Antle, PhD becky.antle@louisville.edu | |
United States, West Virginia | |
Upper Kanawha Clinic | Recruiting |
Cedar Grove, West Virginia, United States, 25039 | |
Contact: Schneider 304-595-1770 | |
Minnie Hamilton Health Systems | Recruiting |
Glenville, West Virginia, United States, 26351 | |
Contact: Behavioral Health Director 304-462-7322 | |
Minnie Hamilton Health Systems | Recruiting |
Grantsville, West Virginia, United States, 26147 | |
Contact: Behavioral Health Director 304-354-9244 | |
Harpers Ferry Family Medicine | Recruiting |
Harpers Ferry, West Virginia, United States, 25425 | |
Contact: Co-Director PBRN 304-535-6343 | |
WVU Medicine | Recruiting |
Morgantown, West Virginia, United States, 26505 | |
Contact: Kari Law klaw@hsc.wvu.edu | |
Wayne Medical Clinic | Recruiting |
Wayne, West Virginia, United States, 25570 | |
Contact: Schneider 304-272-5136 |
Principal Investigator: | Robert Bossarte, PhD | University of South Florida | |
Principal Investigator: | Ronald Kessler, PhD | Harvard Medical School (HMS and HSDM) |
Responsible Party: | Robert Bossarte, Professor, Department of Psychiatry and Behavioral Neuroscience, University of South Florida |
ClinicalTrials.gov Identifier: | NCT04120285 |
Other Study ID Numbers: |
PCS-2017C3-9252 |
First Posted: | October 9, 2019 Key Record Dates |
Last Update Posted: | June 9, 2023 |
Last Verified: | June 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Depression eCBT |
Depressive Disorder Depressive Disorder, Major Mood Disorders Mental Disorders |